Patent · US Active

1,4-bis(3-aminopropyl)piperazine derivative and its use

US10017476B2 · kind B2 · utility

0Cited by

0References

2Claims

0Family size

Assignees

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR
Centre Hospitalier Regional et Universitaire de Lille (CHRU) · FR
UNIVERSITE DE LILLE 2 DROIT ET SANTE · FR

Inventors

Nicolas Sergeant · Ronchin, FR
Luc BUEE · Templemars, FR
Patricia Melnyk · Annœullin, FR
Marion GAY · Lille, FR
Nicolas Le Fur · Rouen, FR

Key dates

Filing date	Mar 16, 2016
Grant date	Jul 10, 2018
Priority date	—
Expiry date	Mar 16, 2036

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P29/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof, and its use in treating and/or preventing a Tauopathy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.